Cretostimogene
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Cretostimogene, covering 2026-03-16 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin [Phase 2]